SCHEMBL30296403

SCHEMBL30296403

Nc1cc(Br)c(C(F)(F)F)cc1F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 2/20 0.37
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA4 P22748 2/20 0.37
CA6 P23280 2/20 0.37
CA5A P35218 2/20 0.37
CA7 P43166 2/20 0.37
CA9 Q16790 2/20 0.37
CA14 Q9ULX7 2/20 0.37
CA5B Q9Y2D0 2/20 0.37
GLA P06280 1/20 0.34
POLB P06746 1/20 0.34
GAA P10253 1/20 0.34
TSHR P16473 1/20 0.34
ADRB2 P07550 5/20 0.34
ALDH1A1 P00352 1/20 0.33
CFTR P13569 1/20 0.33
NOTUM Q6P988 2/20 0.33
CYP11B1 P15538 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26095784 1.00 KIF11 (0.37) KIF11CA12CA1CA2CA4
SCHEMBL1094827 0.91 CA12 (0.41) KIF11CA12CA1CA2CA4
SCHEMBL848016 0.84 CA12 (0.45) CA12CA1CA2CA4CA6
SCHEMBL29399570 0.84 CA12 (0.45) CA12CA1CA2CA4CA6
SCHEMBL24557853 0.83 KDM1A (0.37) KIF11CA12CA1CA2CA4
SCHEMBL30084937 0.82 CA12 (0.39) KIF11CA12CA1CA2CA4
SCHEMBL28920130 0.82 CA12 (0.39) KIF11CA12CA1CA2CA4
SCHEMBL30416102 0.81 NOTUM (0.36) KIF11ADRB2NOTUMCYP11B1CYP11B2
SCHEMBL9227013 0.81 NOTUM (0.36) KIF11ADRB2NOTUMCYP11B1CYP11B2
SCHEMBL31069948 0.79 KIF11 (0.45) KIF11CA12CA1CA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4634161-A2 COMPOUNDS, COMPOSITIONS, AND METHODS Tenvie Therapeutics Inc. (US) 2025-10-22 EP disclosed
EP-4536637-A2 COMPOUNDS, COMPOSITIONS, AND METHODS Nico Therapeutics, Inc. (US) 2025-04-16 EP disclosed
EP-4419203-A1 TRICYCLIC GPR65 MODULATORS Pathios Therapeutics Limited (GB) 2024-08-28 EP disclosed
CN-118451080-A Tricyclic GPR65 modulators 帕蒂奥斯治疗有限公司 2024-08-06 CN disclosed
WO-2024130166-A2 COMPOUNDS, COMPOSITIONS, AND METHODS DENALI THERAPEUTICS INC. (US) 2024-06-20 WO disclosed
CN-117777164-A Nitrogen-containing polycyclic compound, pharmaceutical composition and application thereof 上海璎黎药业有限公司 2024-03-29 CN disclosed
WO-2023240084-A2 COMPOUNDS, COMPOSITIONS, AND METHODS DENALI THERAPEUTICS INC. (US) 2023-12-14 WO disclosed
WO-2023067322-A1 TRICYCLIC GPR65 MODULATORS Pathios Therapeutics Limited (GB) 2023-04-27 WO disclosed